Comparison of prognosis and postoperative morbidities between standard pancreaticoduodenectomy and the TRIANGLE technique for resectable pancreatic ductal adenocarcinoma

doi:10.4240/wjgs.v16.i3.689

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2571)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

111

HTML

971

Figures (1-4)

201

Tables (1-4)

189

Sum=1472

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

179

Download

469

Sum=648

Publishing Process of This Article

Item

Count

Browse

Download

277

Sum=361

Mar 27, 2024 (publication date) through Feb 7, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Surg. Mar 27, 2024; 16(3): 689-699
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.689

Full Size Figure Download Figure

Figure 3 Comparison of overall recurrence rate and local recurrence rate between pancreaticoduodenectomy_standard group and pancreaticoduodenectomy_TRIANGLE group. PD: Pancreaticoduodenectomy.

Citation: Hang HX, Cai ZH, Yang YF, Fu X, Qiu YD, Cheng H. Comparison of prognosis and postoperative morbidities between standard pancreaticoduodenectomy and the TRIANGLE technique for resectable pancreatic ductal adenocarcinoma. World J Gastrointest Surg 2024; 16(3): 689-699
URL: https://www.wjgnet.com/1948-9366/full/v16/i3/689.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i3.689